Form 4: BioLife Solutions EVP Sells Shares for Tax Obligations

BioLife Solutions' EVP and Chief Scientific Officer, Aby J. Mathew, sold 405 shares of common stock to cover tax withholding obligations.

Summary

• Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 405 shares of common stock.
• The transaction occurred on January 6, 2026, at a price of $25.59 per share.
• The sale was executed under a Rule 10b5-1(c) trading plan, which was adopted on January 3, 2023.
• The primary purpose of the sale was to satisfy tax withholding obligations in connection with the vesting of restricted stock.
• Following this transaction, Mr. Mathew beneficially owns 349,350 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale to cover tax obligations under a pre-established plan, which is generally neutral. While it reduces insider holdings, it doesn't signal a change in management's outlook on the company.

Positives

• The sale was pre-planned under a Rule 10b5-1(c) trading plan, indicating it was not a discretionary sale based on new information.
• The sale was specifically to cover tax withholding obligations, a common and expected event for executives receiving equity compensation.

Negatives

• A reduction in direct beneficial ownership by an executive, even if for tax purposes, slightly decreases insider alignment.

Stakeholder Impact

• Minimal impact on shareholders as it is a small, pre-planned, non-discretionary sale for tax purposes.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale by an executive to cover tax withholding obligations associated with restricted stock vesting. Such transactions are common and pre-planned under Rule 10b5-1, indicating no new material information or change in management's sentiment towards the company. Therefore, this specific filing alone does not provide a basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate, pending further fundamental analysis.

Keywords

BioLife Solutions, BLFS, Aby J. Mathew, Insider Trading, Form 4, Stock Sale, Tax Withholding, Rule 10b5-1, Executive Compensation